53 related articles for article (PubMed ID: 25872341)
1. Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.
Fischer JV; Mejia-Bautista M; Vadasz B; Yin P; Bulun S; Tanner EJ; Lu X; Wei JJ
Int J Gynecol Pathol; 2022 Nov; 41(6):552-565. PubMed ID: 35093974
[TBL] [Abstract][Full Text] [Related]
2. High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.
Greco S; Zannotti A; Pellegrino P; Giantomassi F; Delli Carpini G; D'Agostino M; Goteri G; Ciavattini A; Donati C; Bernacchioni C; Petraglia F; La Teana A; Ciarmela P
Reprod Biomed Online; 2023 Jul; 47(1):15-25. PubMed ID: 37137790
[TBL] [Abstract][Full Text] [Related]
3. FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of EPA and DHA in vitro treatments.
Belloni A; Notarstefano V; Greco S; Pellegrino P; Giorgini E; Ciarmela P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166873. PubMed ID: 37666437
[TBL] [Abstract][Full Text] [Related]
4. Outcome analysis in patients with uterine sarcoma.
Yu T; Kim HJ; Wu HG; Ha SW; Song YS; Park NH; Kim JW
Radiat Oncol J; 2015 Mar; 33(1):29-35. PubMed ID: 25874175
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
6. Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
Guo X; Jo VY; Mills AM; Zhu SX; Lee CH; Espinosa I; Nucci MR; Varma S; Forgó E; Hastie T; Anderson S; Ganjoo K; Beck AH; West RB; Fletcher CD; van de Rijn M
Clin Cancer Res; 2015 Aug; 21(15):3501-11. PubMed ID: 25896974
[TBL] [Abstract][Full Text] [Related]
7. Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma.
Alzibdeh A; Mohamad I; Al-Hussaini M; Salah S; Jaradat A; Abuhijlih R; Abuhijla F
World J Oncol; 2024 Feb; 15(1):143-148. PubMed ID: 38274716
[TBL] [Abstract][Full Text] [Related]
8. Surgical Treatment of "Large Uterine Masses" in Pregnancy: A Single-Center Experience.
Cavaliere AF; Vidiri A; Gueli Alletti S; Fagotti A; La Milia MC; Perossini S; Restaino S; Vizzielli G; Lanzone A; Scambia G
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831895
[TBL] [Abstract][Full Text] [Related]
9. A Fast-growing Benign Metastasizing Leiomyoma Mimicking Malignancy.
Hamada N; Ishiga M; Ooue Y; Kimura G; Tanimoto Y
Intern Med; 2022 Jan; 61(2):223-227. PubMed ID: 34275987
[TBL] [Abstract][Full Text] [Related]
10. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS
Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK
Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099
[TBL] [Abstract][Full Text] [Related]
11. Two Rare Cases of Uterine Leiomyosarcomas Originating from Submucosal Leiomyomas Proved by Their Immunohistochemistry Profiles.
Ghorbani H; Ranaee M; Vosough Z
Int J Fertil Steril; 2020 Oct; 14(3):256-259. PubMed ID: 33098395
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcoma of the transverse colon with lymph node metastasis and malignant transformation: a case report.
Tago T; Suzuki S; Kuroda J; Udou R; Nishida K; Oshiro Y; Shimazaki J; Kou K; Morishita Y; Shimoda M
Surg Case Rep; 2020 Oct; 6(1):256. PubMed ID: 33006746
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline
Thibodeau ML; Reisle C; Zhao E; Martin LA; Alwelaie Y; Mungall KL; Ch'ng C; Thomas R; Ng T; Yip S; J Lim H; Sun S; Young SS; Karsan A; Zhao Y; Mungall AJ; Moore RA; J Renouf D; Gelmon K; Ma YP; Hayes M; Laskin J; Marra MA; Schrader KA; Jones SJM
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28514723
[TBL] [Abstract][Full Text] [Related]
15. Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).
Wong JY; Gold EB; Johnson WO; Lee JS
J Clin Endocrinol Metab; 2016 Jan; 101(1):123-30. PubMed ID: 26670127
[TBL] [Abstract][Full Text] [Related]
16. Leiomyosarcoma: a rare malignant transformation of a uterine leiomyoma.
Di Luigi G; D'Alfonso A; Patacchiola F; Di Stefano L; Palermo P; Carta G
Eur J Gynaecol Oncol; 2015; 36(1):84-7. PubMed ID: 25872341
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of uterine leiomyomata.
Indraccolo U; Luchetti G; Indraccolo SR
Eur J Gynaecol Oncol; 2008; 29(5):543-4. PubMed ID: 19051832
[TBL] [Abstract][Full Text] [Related]
18. Leiomyosarcoma: a rare malignant change in a leiomyoma.
Jatoi N
J Coll Physicians Surg Pak; 2003 Feb; 13(2):106-7. PubMed ID: 12685956
[TBL] [Abstract][Full Text] [Related]
19. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
